z-logo
Premium
Are aberrant BCR – ABL transcripts more common than previously thought?
Author(s) -
Wilson G. A.,
Vandenberghe E. A.,
Pollitt R. C.,
Rees D. C.,
Goodeve A. C.,
Peake I. R.,
Reilly J. T.
Publication year - 2000
Publication title -
british journal of haematology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.907
H-Index - 186
eISSN - 1365-2141
pISSN - 0007-1048
DOI - 10.1111/j.1365-2141.2000.02471.x
Subject(s) - breakpoint cluster region , multiplex , exon , breakpoint , multiplex polymerase chain reaction , abl , microbiology and biotechnology , biology , polymerase chain reaction , philadelphia chromosome , cancer research , medicine , genetics , gene , chromosomal translocation , receptor , tyrosine kinase
We report the use of multiplex polymerase chain reaction (PCR), using 4% polyacrylamide gel electrophoresis (PAGE) for the detection of BCR‐ABL transcripts in Philadelphia‐positive disease. Three out of 50 cases [two out of 37 chronic myeloid leukaemia (CML), one out of 13 acute lymphoblastic leukaemia (ALL)] possessed rare breakpoints; an e19a2 and e13a3 in CML and an e1a3 in the ALL. We suggest that multiplex PCR using 4% PAGE and optimized for smaller transcript detection may lead to a higher detection rate of rare BCR‐ABL breakpoints. Multiplex PCR, however, failed to distinguish e13a2 from e1a3 transcripts. Finally, the presence of e13a3 in CML supports the view that abl exon 2 sequences are unnecessary for the pathogenesis of ‘classic’ CML.

This content is not available in your region!

Continue researching here.

Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom